Clinical Study Results
The table below shows the adverse drug reactions that happened during
the study.
Adverse drug reactions that happened during the study
Dapagliflozin + Glimepiride +
Metformin Metformin Total
(Out of 60 (Out of 61 (Out of 121
Adverse drug reaction participants) participants) participants)
Low blood sugar 5.0% (3) 8.2% (5) 6.6% (8)
Weight loss 3.3% (2) 0.0% (0) 1.7% (2)
Frequent need to urinate 1.7% (1) 0.0% (0) 0.8% (1)
Itching in genital area 1.7% (1) 0.0% (0) 0.8% (1)
Swelling in urethra 1.7% (1) 0.0% (0) 0.8% (1)
Trouble urinating 1.7% (1) 0.0% (0) 0.8% (1)
Urinary tract infection 1.7% (1) 0.0% (0) 0.8% (1)
Vaginal itching 1.7% (1) 0.0% (0) 0.8% (1)
Indigestion 0.0% (0) 1.6% (1) 0.8% (1)
Upper stomach pain 0.0% (0) 1.6% (1) 0.8% (1)
None of the participants died during the study.
How has this study helped participants and
researchers?
These results helped researchers learn more about how dapagliflozin affects
the body fat levels compared to glimepiride in patients with type 2 diabetes who
were taking metformin.
Researchers look at the results of many studies to decide which treatments
work best and are safest. This summary shows only the main results from this
1 study. Other studies may provide new information or different results.
Further clinical studies with dapagliflozin are planned.
7